CG Oncology (CGON) Stock Forecast & Price Target

CGON$84.78+10.38 +13.95%
BiotechnologyGrowth Stock
Compare
Market cap$7.57BEnterprise value$5.99BRevenue (TTM)$6.23MMarket position—

Score

53
Neutral
Value
34
Quality
47
Growth
78

CG Oncology Inc. price target

CGON
Low$80.00
Average$86.50
High$100.00
Upside vs current price+2.0%

The average target of $86.50 is +2.0% versus the current CGON price of $84.78.

CG Oncology Inc. analyst ratings

RatingAnalysts
Strong buy4
Buy10
Hold1
Sell0
Strong sell0
ConsensusBuy

15 analysts cover CGON.

CG Oncology Inc. EPS and revenue estimates

The estimate table for the CG Oncology Inc. keeps 2026 EPS $-3.32, 2027 EPS $-3.13, and years with fewer than three analysts are not filled in.

Fiscal yearEPS estimateRevenue estimate
2026$-3.32$4.34M
2027$-3.13$80.64M

Is CG Oncology Inc. a buy or sell?

Of the 15 analysts covering CG Oncology Inc., 14 rate it a buy (4 strong buy and 10 buy), 1 rates it a hold, and 0 rate it a sell (0 sell and 0 strong sell).

The CGON consensus label is Buy, beside 14 buy-side ratings and 0 sell-side ratings.

The average target of $86.50 implies +2.0% versus the current price of $84.78.

the CG Oncology Inc. closes with 14 buy-side ratings and 0 on the sell side. The headcount is Buy.

Reading the CG Oncology Inc. forecast

Between the CGON low of $80.00 and the high of $100.00, the average target is $86.50.

From today's $84.78 print, the CGON average target is +2.0% away.

Most of the CGON coverage agrees: 14 of 15 analysts are on the buy side, 1 is at hold, and 0 are on the sell side, and the published consensus is Buy.

Earnings estimates for CGON are rising: 2026 $-3.32, then 2027 $-3.13.

Coverage of CGON is broad at 15 analysts, and the average is a crowd rather than a single desk.

CG Oncology Inc. forecast questions

What is the CGON price target?

The published range for CGON is $80.00 to $100.00, with an average of $86.50. That average is +2.0% versus the current price of $84.78.

Is CG Oncology Inc. a buy or sell?

Of the 15 analysts covering CG Oncology Inc., 14 rate it a buy, 1 rates it a hold, and 0 rate it a sell. The consensus is Buy, which for CGON is 14 on the buy side, 1 at hold, and 0 on the sell side.

What is the EPS estimate for CG Oncology Inc.?

Analyst EPS estimates for CG Oncology Inc.: 2026 $-3.32, 2027 $-3.13.

What is the revenue estimate for CG Oncology Inc.?

Analyst revenue estimates for CG Oncology Inc.: 2026 $4.34M, 2027 $80.64M.

How many analysts cover CGON?

15 analysts cover CGON. Their consensus on CGON is Buy, across those 15.

CGON price $84.78 +10.38 +13.95%

Insights · Forecast · Financials · Learn

Stocklytics home · Screener